Physician

Ali A Berry, MD

According to 2025 Medicare claims, Ali Berry, MD (NPI: 1427009729) practices dermatology in the Detroit-Dearborn-Livonia, MI market, with the plurality of this provider's patient population coming from Wayne, MI. This provider's primary affiliated billing organization is DERMATOLOGY SPECIALISTS OF CANTON, PLLC (NPI: 1003069014; TIN: 263642932) and primary practice location at 48187-3907.

Berry's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 893 traditional Medicare patients, billed 4,726 HCPCS/CPT codes, and received $164,174 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 692 prescription claims across 263 beneficiaries totaling $345,454 in drug costs, led by Otezla (Apremilast). Open Payments data shows 43 records totaling $966. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $224,434 and ending at $164,174. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $71,396 to $345,454. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$112K$224K2015 Medicare payment: $224,434 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $159,843 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $201,661 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $201,462 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $151,540 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $98,846 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $122,307 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $126,334 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $143,113 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $164,174 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157504,465$224,434
20165902,924$159,843
20176963,544$201,661
20187913,729$201,462
20197213,066$151,540
20204932,226$98,846
20214852,349$122,307
20225142,659$126,334
20236473,049$143,113
20248934,726$164,174

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$173K$345K2015 Drug cost: $71,396 (USD; Tot_Drug_Cst)2016 Drug cost: $94,524 (USD; Tot_Drug_Cst)2017 Drug cost: $124,348 (USD; Tot_Drug_Cst)2018 Drug cost: $118,422 (USD; Tot_Drug_Cst)2019 Drug cost: $154,646 (USD; Tot_Drug_Cst)2020 Drug cost: $168,570 (USD; Tot_Drug_Cst)2021 Drug cost: $187,010 (USD; Tot_Drug_Cst)2022 Drug cost: $242,497 (USD; Tot_Drug_Cst)2023 Drug cost: $253,775 (USD; Tot_Drug_Cst)2024 Drug cost: $345,454 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015300666$71,396
2016281686$94,524
2017281676$124,348
2018311706$118,422
2019287707$154,646
2020228630$168,570
2021212514$187,010
2022203485$242,497
2023241602$253,775
2024263692$345,454

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths261309$83
11102Biopsy of related skin growth, first growth123129$66
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more600734$65
17000Destruction of precancer skin growth, 1 growth302356$40
17003Destruction of precancer skin growth, 2-14 growths2071,080$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OtezlaApremilast23690$109,807
Humira PenAdalimumab14420$97,665
Dupixent SyringeDupilumab12336$48,054
PimecrolimusPimecrolimus14540$3,626
Fluocinolone AcetonideFluocinolone Acetonide411,221$1,589

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.43$966Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ali A. Berry, MD?

Tedicare shows public-source Medicare data for Ali A. Berry, MD (NPI 1427009729), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ali A. Berry, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ali A. Berry, MD?

Ali A. Berry, MD is linked to DERMATOLOGY SPECIALISTS OF CANTON, PLLC (billing NPI 1003069014) in the available physician profile data.

Does Ali A. Berry, MD have Open Payments data?

Ali A. Berry, MD has 43 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.